The Biotech Pulse S1E3 - Empowering Women's Health: A Conversation with Mary Kerr, CEO of NeRRe Therapeutics episode artwork

EPISODE · Feb 8, 2024 · 30 MIN

The Biotech Pulse S1E3 - Empowering Women's Health: A Conversation with Mary Kerr, CEO of NeRRe Therapeutics

from The Biotech Pulse · host Forbion

Episode 3 of "The Biotech Pulse" features Geert-Jan Mulder, Managing Partner and one of the founders of Forbion, interviewing Mary Kerr, CEO of NeRRe Therapeutics. They discuss the challenges and opportunities in women's health, particularly in biotech. Mary shares insights into her career journey, emphasizing the need for more focus on women's health, addressing unmet needs in conditions like endometriosis and fibroids. They also touch on the recent success of KaNDy Therapeutics, a non-hormonal treatment for menopausal symptoms, and its acquisition by Bayer. The conversation highlights the evolving landscape and increasing interest in women's health within the biotech and venture capital sectors.See omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Feb 8, 2024

Embed this episode

Ready to play

The Biotech Pulse S1E3 - Empowering Women's Health: A Conversation with Mary Kerr, CEO of NeRRe Therapeutics

0:00 30:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Biotech Pulse?

This episode is 30 minutes long.

When was this The Biotech Pulse episode published?

This episode was published on February 8, 2024.

Can I download this The Biotech Pulse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!